Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 680 of 6351
-
New blood test aims to detect deadly esophageal cancer before It's too late
Diagnosis Recruiting nowEsophageal squamous cell carcinoma (ESCC) remains a highly lethal cancer worldwide, largely due to late diagnosis. Current screening methods such as upper endoscopy are invasive, operator-dependent, and limited in their ability to detect early-stage lesions. To address this clin…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Could a Fasting-Mimicking diet boost immunotherapy and vitamin c against tough colorectal cancer?
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination with a fasting mimicking diet and high dose vitamin C in treating patients with KRAS-mutant metastatic colorectal cancer. Botensilimab and balstilimab are monoclo…
Phase 1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple supplement soothe Radiation-Damaged rectums?
Symptom relief Recruiting nowThis clinical study is a prospective, single-arm, single-center trial aimed at assessing the safety and efficacy of tributyrin (TB) as dietary supplements in the treatment of chronic radiation-induced rectal injury (RRI). We hypothesize that these supplements will help improve re…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
Disease control Recruiting nowThis phase II trial tests how well cabozantinib in combination with pembrolizumab works in treating patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), that has spread from where it first started (primary site) to other places i…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Simple blood test could spot colon cancer early
Diagnosis Recruiting nowColorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Radiation plus drug cocktail shows promise for resistant lung cancer
Disease control Recruiting nowThe goal of this prospective study is to explore the safety and preliminary efficacy of stereotactic body radiotherapy (SBRT) combined with ORIENT-31 regimen (Sintilimab plus bevacizumab plus platinum-doublet chemotherapy) for advanced epidermal growth factor receptor (EGFR)-muta…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental shot aims to rev up immune system against advanced cancers
Disease control Recruiting nowACM-CpG is a CpG-B TLR9 agonist, which in animal models has led to shrinkage and complete disappearance of injected tumors, durable antitumor memory, and growth inhibitory effects on non-injected tumors while intramuscular administration led to durable control of tumors. This Pha…
Phase 1 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New 15-Strain HPV vaccine trial aims to broaden cancer protection
Vaccine Recruiting nowTo evaluate the safety and Immunogenicity of 15-valent HPV vaccine in 9-45year-old participants.
Phase 2 • Sponsor: Shanghai Bovax Biotechnology Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
New blood test could revolutionize colon cancer staging before surgery
Diagnosis Recruiting nowRecent studies have highlighted the potential benefits of neoadjuvant chemotherapy (NAC) in colon cancer; however, its indication is generally limited to cases corresponding to pathological stage IIB or higher. Accurately identifying such high-risk cases before surgery remains ch…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a dual DNA-RNA approach unlock Parkinson's genetic secrets?
Diagnosis Recruiting nowDespite the increasing availability and advances in the analysis of high-throughput DNA sequencing, the majority of patients with early-onset or familial parkinsonism remain without a molecular diagnosis. Studying the genetic forms of parkinsonian syndromes presents numerous cli…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New combo attack on liver metastases from nasopharyngeal cancer enters human trials
Disease control Recruiting nowThis study aims to evaluate the efficacy and toxicity of adding low-dose radiotherapy to chemoimmunotherapy as a first-line treatment for nasopharyngeal carcinoma patients with liver metastasis.
Phase 2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for older leukemia patients: targeted combo shows promise
Disease control OngoingThis study will be divided into 2 parts (Part 1 and Part 2). Part 1 will evaluate 2 doses of tagraxofusp (9 and 12 micrograms/kilogram/day \[μg/kg/day\]), used in combination with venetoclax and azacitidine, to determine the dose for Part 2. This determined dose, in combination w…
Phase 2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New antibody drug targets HER2 cancers in broad trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors that have Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ overexpression.
Phase 2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Lifestyle boost before breast cancer surgery may improve chemo results
Disease control Recruiting nowThe aim of this clinical trial is to evaluate whether following a multimodal prehabilitation program including physical exercise, nutritional support and psychological intervention during neoadjuvant chemotherapy in breast cancer patients could improve the pathological response t…
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can extra immunotherapy stall advanced lung cancer?
Disease control OngoingThis is a multi-center, double-blind, placebo-controlled randomized phase II study to assess whether continuation of cemiplimab treatment (for up to 12 months) increases progression-free survival (PFS) as compared to placebo in patients with a stage IV, synchronous, oligometastat…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a Finger-Prick test detect Alzheimer's at home?
Diagnosis Recruiting nowThis study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.
Sponsor: Neurogen Biomarking LLC • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New vaccine could stop deadly lassa fever
Vaccine OngoingThis study proposes the evaluation of a novel, first-in-human Lassa fever vaccine based on the complete Lassa glycoprotein complex (GPC) antigen. The antigen will be presented on a genetically modified and attenuated rabies vector expressing both the rabies glycoprotein (GP) anti…
Phase 1 • Sponsor: Wilbur Chen, MD, MS • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New MS drug candidate ABP 692 faces off against ocrevus in major trial
Disease control OngoingThe Main objectives of the study are to demonstrate pharmacokinetic (PK) similarity between ABP 692 and ocrelizumab (US), as well as between ABP 692 and ocrelizumab (EU).
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Breathing battle: can simple exercises ease COPD symptoms?
Symptom relief CompletedPurpose of the Study Chronic Obstructive Pulmonary Disease (COPD) is a progressive, long-term lung condition that limits airflow and makes breathing difficult. People with COPD frequently experience shortness of breath, chronic coughing, and mucus buildup, which can severely impa…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could a psychedelic and brain zapping beat depression?
Symptom relief Recruiting nowThe purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive disorder.
Phase 2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC